Aspirin reduces the risk of type 2 diabetes associated with COVID-19

DOI record: { "DOI": "10.1038/s44324-025-00072-3", "ISSN": [ "2948-2828" ], "URL": "http://dx.doi.org/10.1038/s44324-025-00072-3", "alternative-id": [ "72" ], "article-number": "27", "assertion": [ { "group": { "label": "Article History", "name": "ArticleHistory" }, "label": "Received", "name": "received", "order": 1, "value": "11 March 2025" }, { "group": { "label": "Article History", "name": "ArticleHistory" }, "label": "Accepted", "name": "accepted", "order": 2, "value": "28 May 2025" }, { "group": { "label": "Article History", "name": "ArticleHistory" }, "label": "First Online", "name": "first_online", "order": 3, "value": "18 June 2025" }, { "group": { "label": "Competing interests", "name": "EthicsHeading" }, "name": "Ethics", "order": 1, "value": "The authors declare no competing interests." } ], "author": [ { "affiliation": [], "family": "Trimarco", "given": "Valentina", "sequence": "first" }, { "affiliation": [], "family": "Izzo", "given": "Raffaele", "sequence": "additional" }, { "affiliation": [], "family": "Pacella", "given": "Daniela", "sequence": "additional" }, { "affiliation": [], "family": "Manzi", "given": "Maria Virginia", "sequence": "additional" }, { "affiliation": [], "family": "Jankauskas", "given": "Stanislovas S.", "sequence": "additional" }, { "affiliation": [], "family": "Gallo", "given": "Paola", "sequence": "additional" }, { "affiliation": [], "family": "Rozza", "given": "Francesco", "sequence": "additional" }, { "affiliation": [], "family": "Giugliano", "given": "Giuseppe", "sequence": "additional" }, { "affiliation": [], "family": "Spinelli", "given": "Alessandra", "sequence": "additional" }, { "affiliation": [], "family": "Esposito", "given": "Giovanni", "sequence": "additional" }, { "affiliation": [], "family": "Piccinocchi", "given": "Roberto", "sequence": "additional" }, { "affiliation": [], "family": "Piccinocchi", "given": "Gaetano", "sequence": "additional" }, { "affiliation": [], "family": "Morisco", "given": "Carmine", "sequence": "additional" }, { "affiliation": [], "family": "Lembo", "given": "Maria", "sequence": "additional" }, { "affiliation": [], "family": "Santulli", "given": "Gaetano", "sequence": "additional" }, { "affiliation": [], "family": "Trimarco", "given": "Bruno", "sequence": "additional" } ], "container-title": "npj Metabolic Health and Disease", "container-title-short": "npj Metab Health Dis", "content-domain": { "crossmark-restriction": false, "domain": [ "link.springer.com" ] }, "created": { "date-parts": [ [ 2025, 6, 18 ] ], "date-time": "2025-06-18T10:09:55Z", "timestamp": 1750241395000 }, "deposited": { "date-parts": [ [ 2025, 6, 18 ] ], "date-time": "2025-06-18T11:03:27Z", "timestamp": 1750244607000 }, "funder": [ { "DOI": "10.13039/100000062", "award": [ "R01-DK123259" ], "doi-asserted-by": "publisher", "id": [ { "asserted-by": "publisher", "id": "10.13039/100000062", "id-type": "DOI" } ], "name": "National Institute of Diabetes and Digestive and Kidney Diseases" } ], "indexed": { "date-parts": [ [ 2025, 6, 19 ] ], "date-time": "2025-06-19T04:28:33Z", "timestamp": 1750307313265, "version": "3.41.0" }, "is-referenced-by-count": 0, "issue": "1", "issued": { "date-parts": [ [ 2025, 6, 18 ] ] }, "journal-issue": { "issue": "1", "published-online": { "date-parts": [ [ 2025, 12 ] ] } }, "language": "en", "license": [ { "URL": "https://creativecommons.org/licenses/by-nc-nd/4.0", "content-version": "tdm", "delay-in-days": 0, "start": { "date-parts": [ [ 2025, 6, 18 ] ], "date-time": "2025-06-18T00:00:00Z", "timestamp": 1750204800000 } }, { "URL": "https://creativecommons.org/licenses/by-nc-nd/4.0", "content-version": "vor", "delay-in-days": 0, "start": { "date-parts": [ [ 2025, 6, 18 ] ], "date-time": "2025-06-18T00:00:00Z", "timestamp": 1750204800000 } } ], "link": [ { "URL": "https://www.nature.com/articles/s44324-025-00072-3.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining" }, { "URL": "https://www.nature.com/articles/s44324-025-00072-3", "content-type": "text/html", "content-version": "vor", "intended-application": "text-mining" }, { "URL": "https://www.nature.com/articles/s44324-025-00072-3.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "similarity-checking" } ], "member": "297", "original-title": [], "prefix": "10.1038", "published": { "date-parts": [ [ 2025, 6, 18 ] ] }, "published-online": { "date-parts": [ [ 2025, 6, 18 ] ] }, "publisher": "Springer Science and Business Media LLC", "reference": [ { "author": "RA Stiegmann", "first-page": "11", "journal-title": "MSMR", "key": "72_CR1", "unstructured": "Stiegmann, R. A., Payne, C. B., Kiel, M. A. & Stahlman, S. L. Increased prevalence of overweight and obesity and incidence of prediabetes and type 2 diabetes during the COVID-19 Pandemic, Active Component Service Members, U.S. Armed Forces, 2018 to 2021. MSMR 30, 11–18 (2023).", "volume": "30", "year": "2023" }, { "DOI": "10.3389/fpubh.2023.1170156", "author": "J Li", "doi-asserted-by": "publisher", "journal-title": "Front. Public Health", "key": "72_CR2", "unstructured": "Li, J. et al. Increased risk of new-onset diabetes in patients with COVID-19: a systematic review and meta-analysis. Front. Public Health 11, 1170156 (2023).", "volume": "11", "year": "2023" }, { "DOI": "10.2337/dci22-0067", "author": "WT Cefalu", "doi-asserted-by": "publisher", "first-page": "913", "journal-title": "Diab. Care", "key": "72_CR3", "unstructured": "Cefalu, W. T. COVID-19 and rising incidence of diabetes: despite evolving data, an enigma still to be solved. Diab. Care 46, 913–915 (2023).", "volume": "46", "year": "2023" }, { "DOI": "10.3389/fendo.2023.1215879", "author": "C Bellia", "doi-asserted-by": "publisher", "journal-title": "Front. Endocrinol. ((Lausanne))", "key": "72_CR4", "unstructured": "Bellia, C. et al. Prevalence and risk of new-onset diabetes mellitus after COVID-19: a systematic review and meta-analysis. Front. Endocrinol. ((Lausanne)) 14, 1215879 (2023).", "volume": "14", "year": "2023" }, { "DOI": "10.1001/jamanetworkopen.2024.39444", "doi-asserted-by": "crossref", "key": "72_CR5", "unstructured": "Miller, M. G., Terebuh, P., Kaelber, D. C., Xu, R. & Davis, P. B. SARS-CoV-2 Infection and New-Onset Type 2 Diabetes Among Pediatric Patients, 2020 to 2022. JAMA Netw Open. 7, e2439444 (2024)." }, { "DOI": "10.1038/s42255-020-00339-7", "author": "D Accili", "doi-asserted-by": "publisher", "first-page": "123", "journal-title": "Nat. Metab.", "key": "72_CR6", "unstructured": "Accili, D. Can COVID-19 cause diabetes?. Nat. Metab. 3, 123–125 (2021).", "volume": "3", "year": "2021" }, { "DOI": "10.1056/NEJMc2018688", "author": "F Rubino", "doi-asserted-by": "publisher", "first-page": "789", "journal-title": "N. Engl. J. Med.", "key": "72_CR7", "unstructured": "Rubino, F. et al. New-onset diabetes in Covid-19. N. Engl. J. Med. 383, 789–790 (2020).", "volume": "383", "year": "2020" }, { "DOI": "10.3803/EnM.2023.1662", "author": "JH Choi", "doi-asserted-by": "publisher", "first-page": "245", "journal-title": "Endocrinol. Metab. ((Seoul.))", "key": "72_CR8", "unstructured": "Choi, J. H., Kim, K. M., Song, K. & Seo, G. H. Risk for newly diagnosed type 2 diabetes mellitus after COVID-19 among Korean adults: a Nationwide Matched Cohort Study. Endocrinol. Metab. ((Seoul.)) 38, 245–252 (2023).", "volume": "38", "year": "2023" }, { "DOI": "10.1016/j.metabol.2022.155330", "author": "H Lai", "doi-asserted-by": "publisher", "journal-title": "Metabolism", "key": "72_CR9", "unstructured": "Lai, H. et al. Risk of incident diabetes after COVID-19 infection: a systematic review and meta-analysis. Metabolism 137, 155330 (2022).", "volume": "137", "year": "2022" }, { "DOI": "10.1111/dom.14659", "author": "M Birabaharan", "doi-asserted-by": "publisher", "first-page": "1176", "journal-title": "Diab. Obes. Metab.", "key": "72_CR10", "unstructured": "Birabaharan, M., Kaelber, D. C., Pettus, J. H. & Smith, D. M. Risk of new-onset type 2 diabetes in 600 055 people after COVID-19: a cohort study. Diab. Obes. Metab. 24, 1176–1179 (2022).", "volume": "24", "year": "2022" }, { "DOI": "10.1111/dom.14134", "author": "P Vas", "doi-asserted-by": "publisher", "first-page": "1892", "journal-title": "Diab. Obes. Metab.", "key": "72_CR11", "unstructured": "Vas, P., Hopkins, D., Feher, M., Rubino, F. & B Whyte, M. Diabetes, obesity and COVID-19: a complex interplay. Diab. Obes. Metab. 22, 1892–1896 (2020).", "volume": "22", "year": "2020" }, { "DOI": "10.1016/j.eclinm.2022.101762", "author": "LL O’Mahoney", "doi-asserted-by": "publisher", "journal-title": "EClinicalMedicine", "key": "72_CR12", "unstructured": "O’Mahoney, L. L. et al. The prevalence and long-term health effects of Long Covid among hospitalised and non-hospitalised populations: a systematic review and meta-analysis. EClinicalMedicine 55, 101762 (2023).", "volume": "55", "year": "2023" }, { "DOI": "10.1210/clinem/dgad284", "author": "SH Kim", "doi-asserted-by": "publisher", "first-page": "e1164", "journal-title": "J. Clin. Endocrinol. Metab.", "key": "72_CR13", "unstructured": "Kim, S. H. et al. New-Onset Diabetes After COVID-19. J. Clin. Endocrinol. Metab. 108, e1164–e1174 (2023).", "volume": "108", "year": "2023" }, { "DOI": "10.1016/j.eclinm.2023.102345", "author": "R Izzo", "doi-asserted-by": "publisher", "journal-title": "EClinicalMedicine", "key": "72_CR14", "unstructured": "Izzo, R. et al. Incidence of type 2 diabetes before and during the COVID-19 pandemic in Naples, Italy: a longitudinal cohort study. EClinicalMedicine 66, 102345 (2023).", "volume": "66", "year": "2023" }, { "DOI": "10.1007/s13300-023-01465-7", "author": "A Pantea Stoian", "doi-asserted-by": "publisher", "first-page": "33", "journal-title": "Diab. Ther.", "key": "72_CR15", "unstructured": "Pantea Stoian, A. et al. Cardiometabolic panel of international experts on syndemic C: new-onset diabetes mellitus in COVID-19: a scoping review. Diab. Ther. 15, 33–60 (2024).", "volume": "15", "year": "2024" }, { "DOI": "10.1016/j.cmet.2021.01.016", "author": "DJ Drucker", "doi-asserted-by": "publisher", "first-page": "479", "journal-title": "Cell Metab.", "key": "72_CR16", "unstructured": "Drucker, D. J. Diabetes, obesity, metabolism, and SARS-CoV-2 infection: the end of the beginning. Cell Metab. 33, 479–498 (2021).", "volume": "33", "year": "2021" }, { "DOI": "10.2337/dc21-1318", "author": "K Khunti", "doi-asserted-by": "publisher", "first-page": "2645", "journal-title": "Diab. Care", "key": "72_CR17", "unstructured": "Khunti, K. et al. COVID-19, hyperglycemia, and new-onset diabetes. Diab. Care 44, 2645–2655 (2021).", "volume": "44", "year": "2021" }, { "DOI": "10.3389/fendo.2021.649525", "author": "CP Landstra", "doi-asserted-by": "publisher", "journal-title": "Front. Endocrinol. ((Lausanne))", "key": "72_CR18", "unstructured": "Landstra, C. P. & de Koning, E. J. P. COVID-19 and diabetes: understanding the interrelationship and risks for a severe course. Front. Endocrinol. ((Lausanne)) 12, 649525 (2021).", "volume": "12", "year": "2021" }, { "DOI": "10.1371/journal.pmed.1004274", "author": "X Xiong", "doi-asserted-by": "publisher", "first-page": "e1004274", "journal-title": "PLoS Med.", "key": "72_CR19", "unstructured": "Xiong, X. et al. Incidence of diabetes following COVID-19 vaccination and SARS-CoV-2 infection in Hong Kong: a population-based cohort study. PLoS Med. 20, e1004274 (2023).", "volume": "20", "year": "2023" }, { "DOI": "10.3389/fendo.2022.780663", "doi-asserted-by": "crossref", "key": "72_CR20", "unstructured": "Kazakou, P. et al. Diabetes and COVID-19: a bidirectional interplay. Front. Endocrinol. (Lausanne) 13, 780663 (2022)." }, { "DOI": "10.1210/endocr/bqaa112", "doi-asserted-by": "crossref", "key": "72_CR21", "unstructured": "Bansal, R., Gubbi, S. & Muniyappa, R. Metabolic syndrome and COVID 19: endocrine-immune-vascular interactions shapes clinical course. Endocrinology 161, bqaa112 (2020)." }, { "DOI": "10.1016/j.ajpath.2021.09.004", "author": "JE Johnson", "doi-asserted-by": "publisher", "first-page": "112", "journal-title": "Am. J. Pathol.", "key": "72_CR22", "unstructured": "Johnson, J. E. et al. Coronavirus disease 2019 (COVID-19) coronary vascular thrombosis: correlation with neutrophil but not endothelial activation. Am. J. Pathol. 192, 112–120 (2022).", "volume": "192", "year": "2022" }, { "DOI": "10.3390/jcm9051417", "doi-asserted-by": "crossref", "key": "72_CR23", "unstructured": "Sardu, C. et al. Hypertension, Thrombosis, Kidney Failure, and Diabetes: Is COVID-19 an Endothelial Disease? A Comprehensive Evaluation of Clinical and Basic Evidence. J Clin Med 9, 1417 (2020)." }, { "DOI": "10.3390/antiox12020326", "doi-asserted-by": "crossref", "key": "72_CR24", "unstructured": "Jankauskas, S. S. et al. COVID-19 causes ferroptosis and oxidative stress in human endothelial cells. Antioxidants (Basel) 12, 326 (2023)." }, { "DOI": "10.3390/ijms241411576", "doi-asserted-by": "crossref", "key": "72_CR25", "unstructured": "Grubisic, B. et al. Molecular mechanisms responsible for diabetogenic effects of COVID-19 infection-induction of autoimmune dysregulation and metabolic disturbances. Int. J. Mol. Sci. 24, 11576 (2023)." }, { "DOI": "10.1111/bph.17392", "author": "P Di Pietro", "doi-asserted-by": "publisher", "first-page": "451", "journal-title": "Br. J. Pharm.", "key": "72_CR26", "unstructured": "Di Pietro, P. et al. Plasma miR-1-3p levels predict severity in hospitalized COVID-19 patients. Br. J. Pharm. 182, 451–467 (2025).", "volume": "182", "year": "2025" }, { "DOI": "10.1080/22221751.2025.2492211", "doi-asserted-by": "publisher", "key": "72_CR27", "unstructured": "El-Naas, A. et al. New onset of type 1 and type 2 diabetes post-COVID-19 infection: a systematic review. Emerg. Microbes Infect. https://doi.org/10.1080/22221751.2025.2492211 (2025)." }, { "DOI": "10.1038/s41467-025-59012-w", "author": "LL O’Mahoney", "doi-asserted-by": "publisher", "journal-title": "Nat. Commun.", "key": "72_CR28", "unstructured": "O’Mahoney, L. L. et al. The risk of Long Covid symptoms: a systematic review and meta-analysis of controlled studies. Nat. Commun. 16, 4249 (2025).", "volume": "16", "year": "2025" }, { "author": "OO Oguntibeju", "first-page": "45", "journal-title": "Int. J. Physiol. Pathophysiol. Pharm.", "key": "72_CR29", "unstructured": "Oguntibeju, O. O. Type 2 diabetes mellitus, oxidative stress and inflammation: examining the links. Int. J. Physiol. Pathophysiol. Pharm. 11, 45–63 (2019).", "volume": "11", "year": "2019" }, { "DOI": "10.1111/1753-0407.70014", "author": "R Weinberg Sibony", "doi-asserted-by": "publisher", "journal-title": "J. Diab.", "key": "72_CR30", "unstructured": "Weinberg Sibony, R., Segev, O., Dor, S. & Raz, I. Overview of oxidative stress and inflammation in diabetes. J. Diab. 16, e70014 (2024).", "volume": "16", "year": "2024" }, { "DOI": "10.1056/NEJMoa1803955", "author": "JJ McNeil", "doi-asserted-by": "publisher", "first-page": "1519", "journal-title": "N. Engl. J. Med.", "key": "72_CR31", "unstructured": "McNeil, J. J. et al. Effect of aspirin on all-cause mortality in the healthy elderly. N. Engl. J. Med. 379, 1519–1528 (2018).", "volume": "379", "year": "2018" }, { "DOI": "10.1016/S2213-8587(23)00327-3", "author": "S Zoungas", "doi-asserted-by": "publisher", "first-page": "98", "journal-title": "Lancet Diab. Endocrinol.", "key": "72_CR32", "unstructured": "Zoungas, S. et al. Daily low-dose aspirin and incident type 2 diabetes in community-dwelling healthy older adults: a post-hoc analysis of efficacy and safety in the ASPREE randomised placebo-controlled trial. Lancet Diab. Endocrinol. 12, 98–106 (2024).", "volume": "12", "year": "2024" }, { "DOI": "10.2174/157339906776818532", "author": "JR Greenfield", "doi-asserted-by": "publisher", "first-page": "195", "journal-title": "Curr. Diab. Rev.", "key": "72_CR33", "unstructured": "Greenfield, J. R. & Campbell, L. V. Relationship between inflammation, insulin resistance and type 2 diabetes: ‘cause or effect’?. Curr. Diab. Rev. 2, 195–211 (2006).", "volume": "2", "year": "2006" }, { "DOI": "10.1055/a-2500-0428", "doi-asserted-by": "crossref", "key": "72_CR34", "unstructured": "Zeyfang, A., Wernecke, J. & Bahrmann, A. Diabetes mellitus at an elderly age. Exp. Clin. Endocrinol. Diabetes 133, 168–176 (2025)." }, { "DOI": "10.2337/dc16-1732", "author": "PG Lee", "doi-asserted-by": "publisher", "first-page": "444", "journal-title": "Diab. Care", "key": "72_CR35", "unstructured": "Lee, P. G. & Halter, J. B. The pathophysiology of hyperglycemia in older adults: clinical considerations. Diab. Care 40, 444–452 (2017).", "volume": "40", "year": "2017" }, { "DOI": "10.3390/cells10082115", "doi-asserted-by": "crossref", "key": "72_CR36", "unstructured": "Mone, P. et al. Cognitive impairment in frail hypertensive elderly patients: role of hyperglycemia. Cells 10, 2115 (2021)." }, { "DOI": "10.1172/JCI183777", "doi-asserted-by": "crossref", "key": "72_CR37", "unstructured": "Trimarco, V. et al. A six-year study in a real-world population reveals an increased incidence of dyslipidemia during COVID-19. J. Clin. Invest. 134, e183777 (2024)." }, { "DOI": "10.1016/j.diabres.2024.111926", "author": "V Trimarco", "doi-asserted-by": "publisher", "journal-title": "Diab. Res. Clin. Pract.", "key": "72_CR38", "unstructured": "Trimarco, V. et al. Increased prevalence of cardiovascular-kidney-metabolic syndrome during COVID-19: a propensity score-matched study. Diab. Res. Clin. Pract. 218, 111926 (2024).", "volume": "218", "year": "2024" }, { "DOI": "10.3389/fendo.2020.596898", "doi-asserted-by": "crossref", "key": "72_CR39", "unstructured": "Fignani, D. et al. SARS-CoV-2 receptor angiotensin I-converting enzyme type 2 (ACE2) is expressed in human pancreatic beta-cells and in the human pancreas microvasculature. Front. Endocrinol. (Lausanne) 11, 596898 (2020)." }, { "DOI": "10.1016/j.cmet.2020.11.005", "author": "I Kusmartseva", "doi-asserted-by": "publisher", "first-page": "1041", "journal-title": "Cell Metab.", "key": "72_CR40", "unstructured": "Kusmartseva, I. et al. Expression of SARS-CoV-2 entry factors in the pancreas of normal organ donors and individuals with COVID-19. Cell Metab. 32, 1041–1051.e1046 (2020).", "volume": "32", "year": "2020" }, { "DOI": "10.1172/jci.insight.151551", "doi-asserted-by": "crossref", "key": "72_CR41", "unstructured": "Qadir, M. M. F. et al. SARS-CoV-2 infection of the pancreas promotes thrombofibrosis and is associated with new-onset diabetes. JCI Insight 6, e151551 (2021)." }, { "DOI": "10.1016/j.xcrm.2021.100380", "author": "AL Clark", "doi-asserted-by": "publisher", "journal-title": "Cell Rep. Med.", "key": "72_CR42", "unstructured": "Clark, A. L. & Mirmira, R. G. SARS-CoV-2 infection of islet beta cells: evidence and implications. Cell Rep. Med. 2, 100380 (2021).", "volume": "2", "year": "2021" }, { "DOI": "10.1016/S2213-8587(21)00087-5", "author": "MA Atkinson", "doi-asserted-by": "publisher", "first-page": "328", "journal-title": "Lancet Diab. Endocrinol.", "key": "72_CR43", "unstructured": "Atkinson, M. A. & Powers, A. C. Distinguishing the real from the hyperglycaemia: does COVID-19 induce diabetes?. Lancet Diab. Endocrinol. 9, 328–329 (2021).", "volume": "9", "year": "2021" }, { "DOI": "10.1038/s41467-021-23886-3", "author": "C Steenblock", "doi-asserted-by": "publisher", "journal-title": "Nat. Commun.", "key": "72_CR44", "unstructured": "Steenblock, C. et al. Viral infiltration of pancreatic islets in patients with COVID-19. Nat. Commun. 12, 3534 (2021).", "volume": "12", "year": "2021" }, { "DOI": "10.1111/jdi.13671", "author": "J Shirakawa", "doi-asserted-by": "publisher", "first-page": "2126", "journal-title": "J. Diab. Investig.", "key": "72_CR45", "unstructured": "Shirakawa, J. Pancreatic beta-cell fate in subjects with COVID-19. J. Diab. Investig. 12, 2126–2128 (2021).", "volume": "12", "year": "2021" }, { "DOI": "10.1080/19382014.2021.1954458", "author": "W El-Huneidi", "doi-asserted-by": "publisher", "first-page": "106", "journal-title": "Islets", "key": "72_CR46", "unstructured": "El-Huneidi, W., Hamad, M. & Taneera, J. Expression of SARS-CoV-2 receptor “ACE2” in human pancreatic beta cells: to be or not to be!. Islets 13, 106–114 (2021).", "volume": "13", "year": "2021" }, { "DOI": "10.1038/s41574-021-00481-6", "author": "A Morris", "doi-asserted-by": "publisher", "first-page": "192", "journal-title": "Nat. Rev. Endocrinol.", "key": "72_CR47", "unstructured": "Morris, A. Effects of pancreatic SARS-CoV-2 infection identified. Nat. Rev. Endocrinol. 17, 192 (2021).", "volume": "17", "year": "2021" }, { "DOI": "10.1038/s42255-021-00347-1", "author": "JA Muller", "doi-asserted-by": "publisher", "first-page": "149", "journal-title": "Nat. Metab.", "key": "72_CR48", "unstructured": "Muller, J. A. et al. SARS-CoV-2 infects and replicates in cells of the human endocrine and exocrine pancreas. Nat. Metab. 3, 149–165 (2021).", "volume": "3", "year": "2021" }, { "DOI": "10.1016/j.cmet.2021.05.013", "author": "CT Wu", "doi-asserted-by": "publisher", "first-page": "1565", "journal-title": "Cell Metab.", "key": "72_CR49", "unstructured": "Wu, C. T. et al. SARS-CoV-2 infects human pancreatic beta cells and elicits beta cell impairment. Cell Metab. 33, 1565–1576.e1565 (2021).", "volume": "33", "year": "2021" }, { "DOI": "10.1016/j.cmet.2020.11.006", "author": "KC Coate", "doi-asserted-by": "publisher", "first-page": "1028", "journal-title": "Cell Metab.", "key": "72_CR50", "unstructured": "Coate, K. C. et al. SARS-CoV-2 cell entry factors ACE2 and TMPRSS2 are expressed in the microvasculature and ducts of human pancreas but are not enriched in beta cells. Cell Metab. 32, 1028–1040.e1024 (2020).", "volume": "32", "year": "2020" }, { "DOI": "10.1016/j.cmet.2016.08.020", "author": "A Segerstolpe", "doi-asserted-by": "publisher", "first-page": "593", "journal-title": "Cell Metab.", "key": "72_CR51", "unstructured": "Segerstolpe, A. et al. Single-cell transcriptome profiling of human pancreatic islets in health and type 2 diabetes. Cell Metab. 24, 593–607 (2016).", "volume": "24", "year": "2016" }, { "DOI": "10.2337/db15-0039", "author": "DM Blodgett", "doi-asserted-by": "publisher", "first-page": "3172", "journal-title": "Diabetes", "key": "72_CR52", "unstructured": "Blodgett, D. M. et al. Novel observations from next-generation RNA sequencing of highly purified human adult and fetal islet cell subsets. Diabetes 64, 3172–3181 (2015).", "volume": "64", "year": "2015" }, { "DOI": "10.1016/j.cels.2016.08.011", "author": "M Baron", "doi-asserted-by": "publisher", "first-page": "346", "journal-title": "Cell Syst.", "key": "72_CR53", "unstructured": "Baron, M. et al. A single-cell transcriptomic map of the human and mouse pancreas reveals inter- and intra-cell population structure. Cell Syst. 3, 346–360.e344 (2016).", "volume": "3", "year": "2016" }, { "DOI": "10.1016/j.cmet.2016.04.002", "author": "HE Arda", "doi-asserted-by": "publisher", "first-page": "909", "journal-title": "Cell Metab.", "key": "72_CR54", "unstructured": "Arda, H. E. et al. Age-dependent pancreatic gene regulation reveals mechanisms governing human beta cell function. Cell Metab. 23, 909–920 (2016).", "volume": "23", "year": "2016" }, { "DOI": "10.3390/life11080860", "doi-asserted-by": "crossref", "key": "72_CR55", "unstructured": "D’Ardes, D. et al. Metabolic changes in SARS-CoV-2 infection: clinical data and molecular hypothesis to explain alterations of lipid profile and thyroid function observed in COVID-19 patients. Life (Basel) 11, 860 (2021)." }, { "DOI": "10.1016/S2213-8587(18)30051-2", "author": "E Ahlqvist", "doi-asserted-by": "publisher", "first-page": "361", "journal-title": "Lancet Diab. Endocrinol.", "key": "72_CR56", "unstructured": "Ahlqvist, E. et al. Novel subgroups of adult-onset diabetes and their association with outcomes: a data-driven cluster analysis of six variables. Lancet Diab. Endocrinol. 6, 361–369 (2018).", "volume": "6", "year": "2018" }, { "DOI": "10.1056/NEJMoa2001191", "author": "ML Holshue", "doi-asserted-by": "publisher", "first-page": "929", "journal-title": "N. Engl. J. Med.", "key": "72_CR57", "unstructured": "Holshue, M. L. et al. Washington state -nCo VCIT: first case of 2019 novel coronavirus in the United States. N. Engl. J. Med. 382, 929–936 (2020).", "volume": "382", "year": "2020" }, { "key": "72_CR58", "unstructured": "Lembo, M. et al. Daily low dose aspirin halves incident type 2 diabetes in elderly subjects with prediabetes. A five-year longitudinal cohort study in a real-word population. Cardiovasc Diabetol. 2025; in press." }, { "DOI": "10.3390/cells13191662", "doi-asserted-by": "crossref", "key": "72_CR59", "unstructured": "Pellegrini, V. et al. Inflammatory trajectory of type 2 diabetes: novel opportunities for early and late treatment. Cells 13, 1662 (2024)." }, { "DOI": "10.1345/aph.1M483", "author": "MM Rumore", "doi-asserted-by": "publisher", "first-page": "1207", "journal-title": "Ann. Pharmacother.", "key": "72_CR60", "unstructured": "Rumore, M. M. & Kim, K. S. Potential role of salicylates in type 2 diabetes. Ann. Pharmacother. 44, 1207–1221 (2010).", "volume": "44", "year": "2010" }, { "DOI": "10.4049/jimmunol.0900477", "author": "T Morris", "doi-asserted-by": "publisher", "first-page": "2089", "journal-title": "J. Immunol.", "key": "72_CR61", "unstructured": "Morris, T. et al. Effects of low-dose aspirin on acute inflammatory responses in humans. J. Immunol. 183, 2089–2096 (2009).", "volume": "183", "year": "2009" }, { "DOI": "10.1038/sj.ijo.0802501", "author": "SE Shoelson", "doi-asserted-by": "publisher", "first-page": "S49", "journal-title": "Int J. Obes. Relat. Metab. Disord.", "key": "72_CR62", "unstructured": "Shoelson, S. E., Lee, J. & Yuan, M. Inflammation and the IKK beta/I kappa B/NF-kappa B axis in obesity- and diet-induced insulin resistance. Int J. Obes. Relat. Metab. Disord. 27, S49–S52 (2003).", "volume": "27", "year": "2003" }, { "DOI": "10.1177/1753944707088185", "author": "C Manrique", "doi-asserted-by": "publisher", "first-page": "37", "journal-title": "Ther. Adv. Cardiovasc Dis.", "key": "72_CR63", "unstructured": "Manrique, C., Lastra, G., Palmer, J., Gardner, M. & Sowers, J. R. Aspirin and diabetes mellitus: revisiting an old player. Ther. Adv. Cardiovasc Dis. 2, 37–42 (2008).", "volume": "2", "year": "2008" }, { "DOI": "10.1038/nrendo.2009.109", "author": "G Lastra", "doi-asserted-by": "publisher", "first-page": "365", "journal-title": "Nat. Rev. Endocrinol.", "key": "72_CR64", "unstructured": "Lastra, G. & Whaley-Connell, A. Diabetes: aspirin and prevention of diabetes still a topic of debate. Nat. Rev. Endocrinol. 5, 365–366 (2009).", "volume": "5", "year": "2009" }, { "DOI": "10.4158/EP12064.OR", "author": "E Faghihimani", "doi-asserted-by": "publisher", "first-page": "826", "journal-title": "Endocr. Pract.", "key": "72_CR65", "unstructured": "Faghihimani, E. et al. Reduction of insulin resistance and plasma glucose level by salsalate treatment in persons with prediabetes. Endocr. Pract. 18, 826–833 (2012).", "volume": "18", "year": "2012" }, { "DOI": "10.2337/dc07-1338", "author": "A Fleischman", "doi-asserted-by": "publisher", "first-page": "289", "journal-title": "Diab. Care", "key": "72_CR66", "unstructured": "Fleischman, A., Shoelson, S. E., Bernier, R. & Goldfine, A. B. Salsalate improves glycemia and inflammatory parameters in obese young adults. Diab. Care 31, 289–294 (2008).", "volume": "31", "year": "2008" }, { "DOI": "10.2337/dc08-1206", "author": "AD Pradhan", "doi-asserted-by": "publisher", "first-page": "3", "journal-title": "Diab. Care", "key": "72_CR67", "unstructured": "Pradhan, A. D., Cook, N. R., Manson, J. E., Ridker, P. M. & Buring, J. E. A randomized trial of low-dose aspirin in the prevention of clinical type 2 diabetes in women. Diab. Care 32, 3–8 (2009).", "volume": "32", "year": "2009" }, { "DOI": "10.1056/NEJMoa1804988", "author": "ASC Group", "doi-asserted-by": "publisher", "first-page": "1529", "journal-title": "N. Engl. J. Med.", "key": "72_CR68", "unstructured": "Group, A. S. C. et al. Effects of aspirin for primary prevention in persons with diabetes mellitus. N. Engl. J. Med. 379, 1529–1539 (2018).", "volume": "379", "year": "2018" }, { "DOI": "10.1016/S0140-6736(18)31924-X", "author": "JM Gaziano", "doi-asserted-by": "publisher", "first-page": "1036", "journal-title": "Lancet", "key": "72_CR69", "unstructured": "Gaziano, J. M. et al. Use of aspirin to reduce risk of initial vascular events in patients at moderate risk of cardiovascular disease (ARRIVE): a randomised, double-blind, placebo-controlled trial. Lancet 392, 1036–1046 (2018).", "volume": "392", "year": "2018" }, { "DOI": "10.1007/s00592-022-01927-7", "author": "IN Erthal", "doi-asserted-by": "publisher", "first-page": "1265", "journal-title": "Acta Diabetol.", "key": "72_CR70", "unstructured": "Erthal, I. N. et al. Lifestyle pattern changes, eating disorders, and sleep quality in diabetes: how are the effects of 18 months of COVID-19 pandemic being felt?. Acta Diabetol. 59, 1265–1274 (2022).", "volume": "59", "year": "2022" }, { "DOI": "10.1136/bmjmed-2022-000229", "doi-asserted-by": "crossref", "key": "72_CR71", "unstructured": "Tran, V. T., Perrodeau, E., Saldanha, J., Pane, I. & Ravaud, P. Efficacy of first dose of COVID-19 vaccine versus no vaccination on symptoms of patients with long covid: target trial emulation based on ComPaRe e-cohort. BMJ Med. 2, e000229 (2023)." }, { "DOI": "10.1016/j.eclinm.2022.101624", "author": "KI Notarte", "doi-asserted-by": "publisher", "journal-title": "EClinicalMedicine", "key": "72_CR72", "unstructured": "Notarte, K. I. et al. Impact of COVID-19 vaccination on the risk of developing long-COVID and on existing long-COVID symptoms: a systematic review. EClinicalMedicine 53, 101624 (2022).", "volume": "53", "year": "2022" }, { "DOI": "10.1124/jpet.122.001253", "author": "P Mone", "doi-asserted-by": "publisher", "first-page": "34", "journal-title": "J. Pharm. Exp. Ther.", "key": "72_CR73", "unstructured": "Mone, P. et al. Endothelial extracellular vesicles enriched in microRNA-34a predict new-onset diabetes in coronavirus disease 2019 (COVID-19) patients: novel insights for long COVID metabolic sequelae. J. Pharm. Exp. Ther. 389, 34–39 (2024).", "volume": "389", "year": "2024" }, { "DOI": "10.1016/j.eclinm.2021.101125", "author": "G Fiorentino", "doi-asserted-by": "publisher", "journal-title": "EClinicalMedicine", "key": "72_CR74", "unstructured": "Fiorentino, G. et al. Effects of adding L-arginine orally to standard therapy in patients with COVID-19: a randomized, double-blind, placebo-controlled, parallel-group trial. Results of the first interim analysis. EClinicalMedicine 40, 101125 (2021).", "volume": "40", "year": "2021" }, { "DOI": "10.1186/s13054-021-03731-1", "author": "J Gambardella", "doi-asserted-by": "publisher", "journal-title": "Crit. Care", "key": "72_CR75", "unstructured": "Gambardella, J. et al. Role of endothelial miR-24 in COVID-19 cerebrovascular events. Crit. Care 25, 306 (2021).", "volume": "25", "year": "2021" }, { "DOI": "10.1016/S2213-8587(22)00044-4", "author": "Y Xie", "doi-asserted-by": "publisher", "first-page": "311", "journal-title": "Lancet Diab. Endocrinol.", "key": "72_CR76", "unstructured": "Xie, Y. & Al-Aly, Z. Risks and burdens of incident diabetes in long COVID: a cohort study. Lancet Diab. Endocrinol. 10, 311–321 (2022).", "volume": "10", "year": "2022" }, { "DOI": "10.1161/CIR.0000000000001040", "author": "JJ Joseph", "doi-asserted-by": "publisher", "first-page": "e722", "journal-title": "Circulation", "key": "72_CR77", "unstructured": "Joseph, J. J. et al. Comprehensive management of cardiovascular risk factors for adults with type 2 diabetes: a scientific statement from the American Heart Association. Circulation 145, e722–e759 (2022).", "volume": "145", "year": "2022" }, { "DOI": "10.1161/CIRCULATIONAHA.110.009449", "author": "R Mehran", "doi-asserted-by": "publisher", "first-page": "2736", "journal-title": "Circulation", "key": "72_CR78", "unstructured": "Mehran, R. et al. Standardized bleeding definitions for cardiovascular clinical trials: a consensus report from the Bleeding Academic Research Consortium. Circulation 123, 2736–2747 (2011).", "volume": "123", "year": "2011" }, { "DOI": "10.2337/dc22-0783", "author": "P Mone", "doi-asserted-by": "publisher", "first-page": "450", "journal-title": "Diab. Care", "key": "72_CR79", "unstructured": "Mone, P. et al. Stress hyperglycemia drives the risk of hospitalization for chest pain in patients with ischemia and nonobstructive coronary arteries (INOCA). Diab. Care 46, 450–454 (2023).", "volume": "46", "year": "2023" }, { "DOI": "10.1186/s12933-025-02798-2", "author": "M Lembo", "doi-asserted-by": "publisher", "first-page": "233", "journal-title": "Cardiovasc Diabetol", "key": "72_CR80", "unstructured": "Lembo, M. et al. Statin-induced risk of diabetes does not reduce cardiovascular benefits in primary prevention: a 6-year propensity-score matched study in a large population. Cardiovasc Diabetol 24, 233 (2025).", "volume": "24", "year": "2025" } ], "reference-count": 80, "references-count": 80, "relation": {}, "resource": { "primary": { "URL": "https://www.nature.com/articles/s44324-025-00072-3" } }, "score": 1, "short-title": [], "source": "Crossref", "subject": [], "subtitle": [], "title": "Aspirin reduces the risk of type 2 diabetes associated with COVID-19", "type": "journal-article", "update-policy": "https://doi.org/10.1007/springer_crossmark_policy", "volume": "3" }